Larisa V Gubareva Selected Research

N-Acetylneuraminic Acid (Sialic Acid)

1/2017	Quantification of Influenza Neuraminidase Activity by Ultra-High Performance Liquid Chromatography and Isotope Dilution Mass Spectrometry.
2/2010	Bifunctional polymeric inhibitors of human influenza A viruses.
10/2005	Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Larisa V Gubareva Research Topics

Disease

71	Human Influenza (Influenza) 10/2023 - 12/2002
34	Infections 12/2022 - 03/2006
9	Influenza in Birds (Avian Flu) 01/2023 - 04/2006
3	Virus Diseases (Viral Diseases) 10/2021 - 02/2012
2	Body Weight (Weight, Body) 12/2016 - 05/2015
2	Weight Loss (Weight Reduction) 04/2014 - 03/2006
1	Hemolysis 04/2014
1	Conjunctivitis 03/2012
1	Herpesviridae Infections (Herpesvirus Infection) 06/2010
1	Orthomyxoviridae Infections 03/2010

Drug/Important Bio-Agent (IBA)

42	Neuraminidase (Sialidase)IBA 10/2023 - 07/2004
34	Oseltamivir (Tamiflu)FDA Link 10/2021 - 03/2006
31	Antiviral Agents (Antivirals)IBA 01/2023 - 03/2009
11	Zanamivir (Relenza)FDA Link 10/2021 - 03/2008
9	Hemagglutinins (Hemagglutinin)IBA 01/2017 - 12/2002
6	baloxavirIBA 12/2022 - 01/2019
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2006
4	VaccinesIBA 10/2017 - 11/2009
4	oplunofuspIBA 08/2014 - 04/2006
4	AdamantaneIBA 01/2012 - 07/2009
3	Amino Acids FDA Link 10/2023 - 04/2009
3	Monoclonal AntibodiesIBA 12/2022 - 01/2011
3	EndonucleasesIBA 01/2022 - 01/2019
3	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2017 - 10/2005
3	peramivirIBA 09/2013 - 08/2006
2	EnzymesIBA 12/2022 - 09/2010
2	Immune Sera (Antisera)IBA 12/2022 - 04/2014
2	laninamivirIBA 09/2013 - 01/2013
2	cyanovirin NIBA 12/2008 - 01/2007
1	AntigensIBA 10/2017
1	IsotopesIBA 01/2017
1	AntibodiesIBA 01/2017
1	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2016
1	NucleotidesIBA 08/2012
1	PolymersIBA 03/2011
1	favipiravirIBA 06/2010
1	Amantadine (Aman)FDA LinkGeneric 03/2010
1	Rimantadine FDA LinkGeneric 03/2010
1	poly(isobutylene-alt-maleic anhydride)IBA 02/2010
1	Tyrosine (L-Tyrosine)FDA Link 04/2009
1	Histidine (L-Histidine)FDA Link 04/2009
1	Ribavirin (Virazole)FDA LinkGeneric 12/2008
1	PlacebosIBA 12/2008
1	N,N-dodecyl,methyl-polyethylenimineIBA 03/2008
1	methyl inosine monophosphate (MIMP)IBA 08/2006
1	Inosine FDA Link 08/2006
1	Immunologic Factors (Immunomodulators)IBA 08/2006
1	Sialic AcidsIBA 04/2006
1	Recombinant Fusion ProteinsIBA 04/2006
1	sialic acid receptorIBA 04/2006
1	A-322278IBA 03/2006
1	Polysaccharides (Glycans)IBA 10/2005

Therapy/Procedure

7	Therapeutics 12/2016 - 03/2006
2	Chemoprevention 01/2012 - 01/2012
1	Treatment Delay 12/2016
1	Long-Term Care 12/2009
1	Aftercare (After-Treatment) 12/2008